Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 751 clinical trials
featured
A Phase 3, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy, Safety, And Tolerability Of Atogepant For The Prevention Of Chronic Migraine (PROGRESS)

. Treatment groups include 30mg twice daily, 60mg once daily, and placebo. This study will consist of a 4-week screening and baseline period, a 12-week double-blind treatment period

  • 260 views
  • 03 Aug, 2020
  • 1 location
featured
A double-blind, randomized, parallel-group vehicle-controlled, multi-center study comparing a generic tazarotene cream, 0.05% to reference listed drug tazorac (tazarotene) cream, 0.05% and both active treatments to a vehicle control in the treatment of plaque psoriasis

A double-blind, randomized, parallel-group vehicle-controlled, multi-center study comparing a generic tazarotene cream, 0.05% to reference listed drug tazorac (tazarotene) cream, 0.05% and both active treatments to a vehicle control in the treatment of plaque psoriasis

  • 186 views
  • 08 Nov, 2020
  • 1 location
featured
A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients

A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients

  • 498 views
  • 08 Nov, 2020
  • 1 location
featured
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of XXXXXX in Patients with Irritable Bowel Syndrome with Constipation (IBS-C)

Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of XXXXXX in Patients with Irritable Bowel Syndrome with Constipation (IBS-C)

  • 644 views
  • 08 Nov, 2020
  • 1 location
featured
A Phase 2, Randomized, Double-Blind, Multicenter, Parallel-Group, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dose Levels of XP23829 in Subjects with Moderate-to-Severe Chronic Plaque-Type Psoriasis

A Phase 2, Randomized, Double-Blind, Multicenter, Parallel-Group, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dose Levels of XP23829 in Subjects with Moderate-to-Severe Chronic Plaque-Type Psoriasis

  • 278 views
  • 08 Nov, 2020
  • 1 location
featured
Longitudinal Gait and Balance Measurement

Longitudinal Gait and Balance Measurement

  • 190 views
  • 23 Nov, 2020
  • 1 location
featured
Investigational Irritable Bowel Syndrome with Constipation (IBS-C) Study

Investigational Irritable Bowel Syndrome with Constipation (IBS-C) Study

  • 480 views
  • 08 Nov, 2020
  • 1 location
featured
An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder

An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder

  • 394 views
  • 23 Nov, 2020
  • 1 location
featured
Study of NUEDEXTA in the Treatment of Pseudobulbar Affect (PBA)

Study of NUEDEXTA in the Treatment of Pseudobulbar Affect (PBA)

  • 74 views
  • 08 Nov, 2020
  • 1 location
featured
Quit Smoking Study Ages 12 to 19 years

Quit Smoking Study Ages 12 to 19 years

  • 674 views
  • 08 Nov, 2020
  • 1 location